» Articles » PMID: 25634539

DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity

Overview
Journal Toxicol Sci
Specialty Toxicology
Date 2015 Jan 31
PMID 25634539
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

It was reported that aminochrome induces the formation of alpha synuclein (SNCA) oligomers during dopamine oxidation. We found that DT-diaphorase (NQO1) prevents the formation of SNCA oligomers in the presence of aminochrome determined by Western blot, transmission electron microscopy, circular dichroism, and thioflavin T fluorescence, suggesting a protective role of NQO1 by preventing the formation of SNCA oligomers in dopaminergic neurons. In order to test NQO1 protective role in SNCA neurotoxicity in cellular model, we overexpressed SNCA in both RCSN-3 cells (wild-type) and RCSN-3Nq7 cells, which have constitutive expression of a siRNA against NQO1. The expression of SNCA in RCSN-3SNCA and RCSN-3Nq7SNCA cells increased 4.2- and 4.4-fold, respectively. The overexpression of SNCA in RCSN-3Nq7SNCA cells induces a significant increase in cell death of 2.8- and 3.2-fold when they were incubated with 50 and 70 µM aminochrome, respectively. The cell death was found to be of apoptotic character determined by annexin/propidium iodide technique with flow cytometry and DNA laddering. A Western blot demonstrated that SNCA in RCSN-3SNCA is only found in monomer form both in the presence of 20 µM aminochrome or cell culture medium contrasting with RCSN-3Nq7SNCA cells where the majority SNCA is found as oligomer. The antioligomer compound scyllo-inositol induced a significant decrease in aminochrome-induced cell death in RCSN-3Nq7SNCA cells in comparison to cells incubated in the absence of scyllo-inositol. Our results suggest that NQO1 seems to play an important role in the prevention of aminochrome-induced SNCA oligomer formation and SNCA oligomers neurotoxicity in dopaminergic neurons.

Citing Articles

Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease.

Huenchuguala S, Segura-Aguilar J Antioxidants (Basel). 2024; 13(9).

PMID: 39334784 PMC: 11428591. DOI: 10.3390/antiox13091125.


Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration Model.

Huenchuguala S, Segura-Aguilar J Biomolecules. 2024; 14(6).

PMID: 38927076 PMC: 11201619. DOI: 10.3390/biom14060673.


Single-neuron neurodegeneration as a degenerative model for Parkinson's disease.

Huenchuguala S, Segura-Aguilar J Neural Regen Res. 2023; 19(3):529-535.

PMID: 37721280 PMC: 10581573. DOI: 10.4103/1673-5374.380878.


A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.

Segura-Aguilar J, Mannervik B Antioxidants (Basel). 2023; 12(3).

PMID: 36978921 PMC: 10045214. DOI: 10.3390/antiox12030673.


Protective Effects of Flavonoid Rutin Against Aminochrome Neurotoxicity.

De Araujo F, Frota A, de Jesus L, Cuenca-Bermejo L, Ferreira K, Santos C Neurotox Res. 2023; 41(3):224-241.

PMID: 36723781 DOI: 10.1007/s12640-022-00616-1.


References
1.
Huenchuguala S, Munoz P, Zavala P, Villa M, Cuevas C, Ahumada U . Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction. Autophagy. 2014; 10(4):618-30. PMC: 4091149. DOI: 10.4161/auto.27720. View

2.
Segura-Aguilar J, Kaiser R, Lind C . Separation and characterization of isoforms of DT-diaphorase from rat liver cytosol. Biochim Biophys Acta. 1992; 1120(1):33-42. DOI: 10.1016/0167-4838(92)90421-9. View

3.
Conway K, Rochet J, Bieganski R, Lansbury Jr P . Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science. 2001; 294(5545):1346-9. DOI: 10.1126/science.1063522. View

4.
Volles M, Lansbury Jr P . Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry. 2003; 42(26):7871-8. DOI: 10.1021/bi030086j. View

5.
Martin Z, Neugebauer V, Dineley K, Kayed R, Zhang W, Reese L . α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J Neurochem. 2011; 120(3):440-52. PMC: 3253169. DOI: 10.1111/j.1471-4159.2011.07576.x. View